Nome Químico: (3S,4R,5R,6S)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-((((3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
Sorrisos: CCOC1=CC=C(CC2=C(Cl)C=CC(C3(OC[C@@H]4OC(C5=CC=C(Cl)C(CC6=CC=C(OCC)C=C6)=C5)(OC)[C@@H](O)[C@H](O)[C@H]4O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)=C2)C=C1
Stability indicating rp-hplc method for simultaneous estimation of dapagliflozin and saxagliptin in pharmaceutical dosage forms
By Thota, Hanisha; Soundarya, G.
From Journal of Global Trends in Pharmaceutical Sciences (2021), 12(1), 9131-9137
Method development and validation of a stability-indicating reversed-phase liquid chromatographic method for the simultaneous estimation of metformin and dapagliflozin in presence of their degradation products
By Kotecha, Nidhi; Patel, Jayvadan
From International Journal of Pharmaceutical Sciences Review and Research (2019), 56(2), 1-6.
Validation of a newly developed stability indicating RP-liquid chromatographic method for the quantitative determination of dapagliflozin
By Sura, Sreenivasulu; Modalavalasa, Rameswara Rao; Kothapalli, ChandraSekhar B.
From Pharma Chemica (2018), 10(1), 93-102